User Perspectives on Professional Support and Service Use During Psychiatric Medication Discontinuation.
Discontinuation
Provider relationships
Psychiatric medication
Service user perspectives
Journal
Community mental health journal
ISSN: 1573-2789
Titre abrégé: Community Ment Health J
Pays: United States
ID NLM: 0005735
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
received:
10
02
2021
accepted:
11
12
2021
pubmed:
13
1
2022
medline:
24
8
2022
entrez:
12
1
2022
Statut:
ppublish
Résumé
Psychiatric medication discontinuation is common and can have negative impacts. Until recently, most research on discontinuation happened in an adherence/compliance framework. There is now recognition that discontinuation may be a desired goal for many individuals. The purpose of the present paper is to describe the results of a pioneering survey to explore professional support to service users during medication discontinuation to inform clinical practice and guide future research. Survey responses from 250 service users were summarized with regard to their use of prescriber and psychotherapy services during the process of discontinuing psychiatric medication. Only 65% of respondents reported seeing a prescriber and less than 50% reported seeing a psychotherapist while attempting to discontinue psychiatric medication. Combined with respondents' answers describing the decision-making process and support received from these services, this paper identifies gaps in service and the need to improve providers' ability to support individuals while they discontinue psychiatric medication.
Identifiants
pubmed: 35020115
doi: 10.1007/s10597-021-00933-3
pii: 10.1007/s10597-021-00933-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1416-1424Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Carey, B. & Gebeloff, B. (2018). Many people taking antidepressants discover they cannot quit. The New York Times. http://www.nytimes.com
Chouinard, G., & Chouinard, V. A. (2008). Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes. Psychotherapy and Psychosomatics, 77(2), 69–77. https://doi.org/10.1159/000112883
doi: 10.1159/000112883
pubmed: 18230939
Cohen, D., & Recalt, A. M. (2019). Discontinuing psychotropic drugs from participants in randomized controlled trials: A systematic review. Psychotherapy and Psychosomatics, 88(2), 96–104.
doi: 10.1159/000496733
Dixon, L. B., Holoshitz, Y., & Nossel, I. (2016). Treatment engagement of individuals experiencing mental illness: Review and update. World Psychiatry, 15(1), 13–20.
doi: 10.1002/wps.20306
Easter, A., Pollock, M., Pope, L. G., Wisdom, J. P., & Smith, T. E. (2015). Perspectives of treatment providers and clients with serious mental illness regarding effective therapeutic relationships. The Journal of Behavioral Health Services & Research, 43(3), 341–353. https://doi.org/10.1007/s11414-015-9492-5
doi: 10.1007/s11414-015-9492-5
El-Mallakh, P., & Findlay, J. (2015). Strategies to improve medication adherence in patients with schizophrenia: The role of support services. Neuropsychiatric Disease and Treatment, 11, 1077–1090. https://doi.org/10.2147/NDT.S56107
doi: 10.2147/NDT.S56107
pubmed: 25931823
pmcid: 4404876
Fava, G. A. (2003). Can long-term treatment with antidepressant drugs worsen the course of depression? Journal of Clinical Psychiatry, 64, 123–133.
doi: 10.4088/JCP.v64n0204
Gibson, K., Cartwright, C., & Read, J. (2014). Patient-centered perspectives on antidepressant use. International Journal of Mental Health, 43(1), 81–99. https://doi.org/10.2753/IMH0020-7411430105
doi: 10.2753/IMH0020-7411430105
Gibson, K., Cartwright, C., & Read, J. (2016). ‘In my life antidepressants have been…’: A qualitative analysis of users’ diverse experiences with antidepressants. BMC Psychiatry. https://doi.org/10.1186/s12888-016-0844-3
doi: 10.1186/s12888-016-0844-3
pubmed: 27165309
pmcid: 4863327
Green, C. A., Polen, M. R., Janoff, S. L., Castleton, D. K., Wisdom, J. P., Vuckovic, N., Perrin, N. A., Paulson, R. I., & Oken, S. L. (2008). Understanding how clinician-patient relationships and relational continuity of care affect recovery from serious mental illness: STARS study results. Psychiatric Rehabilitation Journal, 32(1), 9–22. https://doi.org/10.2975/32.1.2008.9.22
doi: 10.2975/32.1.2008.9.22
pubmed: 18614445
pmcid: 2573468
Gupta, S., & Cahill, J. D. (2016). A prescription for “deprescribing” in psychiatry. Psychiatric Services, 67(8), 904–907.
doi: 10.1176/appi.ps.201500359
Hasson-Ohayon, I. (2018). Overlap and distinction between measures of insight and self-stigma. Psychiatric Research, 266, 47–64.
doi: 10.1016/j.psychres.2018.05.035
Katz, S., Goldblatt, H., Hasson-Ohayon, I., & Roe, D. (2019). Retrospective accounts of the process of using and discontinuing psychiatric medication. Qualitative Health Research, 29(2), 198–210. https://doi.org/10.1177/1049732318793418
doi: 10.1177/1049732318793418
pubmed: 30132725
Keisler-Starkey, K. & Bunch, L.N. (2020). Health insurance coverage in the United States: 2019. U.S. Census Bureau Current Population Reports, pp 60–271.
National Institute for Health and Care Excellence (NICE). (2009). Depression in adults: recognition and management. www.nice.org.uk/guidance/cg90 .
Morant, N., Azam, K., Johnson, S., & Moncrieff, J. (2018). The least worst option: User experiences of antipsychotic medication and lack of involvement in medication decisions in a UK community sample. Journal of Mental Health, 27(4), 322–328. https://doi.org/10.1080/09638237.2017.1370637
doi: 10.1080/09638237.2017.1370637
pubmed: 28857636
Ostrow, L., Croft, B., Weaver, A., & Naeger, S. (2019). An exploratory analysis of the role of social supports in psychiatric medication discontinuation: Results related to family involvement. Psychosis, 11(3), 212–222.
doi: 10.1080/17522439.2019.1615110
Ostrow, L., Jessell, L., Hurd, M., Darrow, S. M., & Cohen, D. (2017). Discontinuing psychiatric medications: A survey of long-term users. Psychiatric Services, 68(12), 1232–1238. https://doi.org/10.1176/appi.ps.201700070
doi: 10.1176/appi.ps.201700070
pubmed: 28712356
Read, J., Cartwright, C., & Gibson, K. (2018). How many of 1829 antidepressant users report withdrawal effects or addiction? International Journal of Mental Health Nursing, 27(6), 1805–1815. https://doi.org/10.1111/inm.12488
doi: 10.1111/inm.12488
pubmed: 29873165
Read, J., & Williams, J. (2018). Adverse effects of antidepressants reported by a large international cohort: Emotional blunting, suicidality, and withdrawal effects. Current Drug Safety, 13(3), 176–186. https://doi.org/10.2174/1574886313666180605095130
doi: 10.2174/1574886313666180605095130
pubmed: 29866014
Ride, J., Kasteridis, P., Gutacker, N., Doran, T., Rice, N., Gravelle, H., Kendrick, T., Mason, A., Goddard, M., Siddiqi, N., Gilbody, S., Williams, R., Aylott, L., Dare, C., & Jacobs, R. (2019). Impact of family practice continuity of care on unplanned hospital use for people with serious mental illness. Health Services Research, 54(6), 44.
doi: 10.1111/1475-6773.13211
Robiner, W. N., Tompkins, T. L., & Hathaway, K. M. (2019). Prescriptive authority: Psychologists’ abridged training relative to other professions’ training. Clinical Psychology: Science and Practice, 27(1), 58.
Roe, D., & Davidson, L. (2017). Noncompliance, nonadherence, and dropout: Outmoded terms for modern recovery-oriented mental health. Psychiatric Services, 68(10), 1076–1078. https://doi.org/10.1176/appi.ps.201600522
doi: 10.1176/appi.ps.201600522
pubmed: 28669286
Roe, D., Goldblatt, H., Baloush-Klienman, V., Swarbrick, M., & Davidson, L. (2009). Why and how people decide to stop taking prescribed psychiatric medication: Exploring the subjective process of choice. Psychiatric Rehabilitation Journal, 33(1), 38–46. https://doi.org/10.2975/33.1.2009.38.46
doi: 10.2975/33.1.2009.38.46
pubmed: 19592378
Roe, D., Jones, N., Hasson-Ohayon, I., & Zisman-Ilani, Y. (2021). Conceptualization and study of antipsychotic medication use: From adherence to pattern of use. Psychiatric Services, 00, 1–3.
Russo, J. (2018). Through the eyes of the observed: Re-directing research on psychiatric drugs. Talking Point Papers, 3.
Salyers, M. P., & Zisman-Ilani, Y. (2020). Shared decision-making and self-directed care. In H. H. Goldman, R. G. Frank, & J. P. Morrissey (Eds.), The palgrave handbook of American mental health policy (pp. 197–228). Springer International Publishing.
doi: 10.1007/978-3-030-11908-9_8
Semahegn, A., Torpey, K., Manu, A., Assefa, N., Tesfaye, G., & Ankomah, A. (2018). Psychotropic medication non-adherence and associated factors among adult patients with major psychiatric disorders: A protocol for a systematic review. Systematic Reviews, 7(1), 10. https://doi.org/10.1186/s13643-018-0676-y
doi: 10.1186/s13643-018-0676-y
pubmed: 29357926
pmcid: 5778728
Slade, M. (2017). Implementing shared decision making in routine mental health care. World Psychiatry, 16(2), 146–153.
doi: 10.1002/wps.20412
Stanhope, V., Tondora, J., Davidson, L., Choy-Brown, M., & Marcus, S. C. (2015). Person-centered care planning and service engagement: a study protocol for a randomized controlled trial. Trials. https://doi.org/10.1186/s13063-015-0715-0
doi: 10.1186/s13063-015-0715-0
pubmed: 25897762
pmcid: 4409728
Stein, B. D., Kogan, J. N., Mihalyo, M. J., Schuster, J., Deegan, P. E., Sorbero, M. J., & Drake, R. E. (2013). Use of a computerized medication shared decision making tool in community mental health settings: Impact on psychotropic medication adherence. Community Mental Health Journal, 49(2), 185–192.
doi: 10.1007/s10597-012-9528-8
The International Early Psychosis Association writing Group. (2005). International clinical practice guidelines for early psychosis. British Journal of Psychiatry, 187(suppl. 48), s120–s124.
doi: 10.1192/bjp.187.48.s120
Tobon, A. L., Flores, J. M., Taylor, J. H., Johnson, I., Landeros-Weisenberger, A., Aboiralor, O., Avila-Quintero, V. J., & Bloch, M. H. (2021). Racial implicit associations in psychiatric diagnosis, treatment, and compliance expectations. Academic Psychiatry, 45, 23–33.
doi: 10.1007/s40596-020-01370-2
White, E., Read, J., & Julo, S. (2021). The role of Facebook groups in the management, and raising of awareness of, antidepressant withdrawal: Is social media filling the void left by health services? Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125320981174
doi: 10.1177/2045125320981174
pubmed: 33520155
pmcid: 7816538
Zisman-Ilani, Y., Barnett, E., Harik, J., Pavlo, A., & O’Connell, M. (2017). Expanding the concept of shared decision making for mental health: Systematic search and scoping review of interventions. Mental Health Review Journal, 22(3), 191–213. https://doi.org/10.1108/MHRJ-01-2017-0002
doi: 10.1108/MHRJ-01-2017-0002
Zisman-Ilani, Y., Lysaker, P. H., & Hasson-Ohayon, I. (2021). Shared risk taking: Shared decision making in serious mental illness. Psychiatric Services, 72(4), 461–463. https://doi.org/10.1176/appi.ps.202000156
doi: 10.1176/appi.ps.202000156
pubmed: 33557595
Zisman-Ilani, Y., Roe, D., Elwyn, G., Kupermintz, H., Patya, N., Peleg, I., & Karnieli-Miller, O. (2019). Shared decision making for psychiatric rehabilitation services before discharge from psychiatric hospitals. Health Communication, 34(6), 631–637. https://doi.org/10.1080/10410236.2018.1431018
doi: 10.1080/10410236.2018.1431018
pubmed: 29393685
Zisman-Ilani, Y., Shern, D., Deegan, P., Kreyenbuhl, J., Dixon, L., Drake, R., Torrey, W., Mishra, M., Gorbenko, K., & Elwyn, G. (2018). Continue, adjust, or stop antipsychotic medication: Developing and user testing an encounter decision aid for people with first-episode and long-term psychosis. BMC Psychiatry, 18(1), 142.
doi: 10.1186/s12888-018-1707-x